interesting that filtering the liquid can help people.
. MSCs produce a variety of neurogenic, neuroprotective, and immunomodulatory agents [15,16,17,18,19,20,21], and have been shown to induce beneficial effects when transplanted in EAE-mice [22,23,24,25], stroke [26,27], traumatic brain injury [28], Parkinson’s disease [29], schizophrenia, and autism [30,31] as well as increased neurogenesis in adult mice
Moreover, no studies using biologically enriched-aCSF for exchanging the CSF have been published.
That makes me want to search hard for studies that do involve the transfer, however I would have to figure out a way to create an experiment around this base idea of artificial CSF.
Artifical cerebrospinal fluid (aCSF) enriched with secretions of mesenchymal stem cells (MSCs) increases cell viability of PC12 and SH-SY5Y neuronal cell lines
While secretions of 2 days growing 10 or 100 K/mL MSCs in aCSF did not show an increase in PC12 cell viability
HMMM.... that is utterly fascinating the fact that after 2 days there seemed to be no change amongst the cell viability for both the 10 and 100 ml aCSF.
etions of 5 days growing MSCs in aCSF did show a significant increase in the PC12 cell viability relative to unenriched-aCSF treated cells
The principle of CSF exchange is similar to plasma exchange by plasmapheresis, which is in use for the treatment of autoimmune disorders
Did not know that it was similar to plasmapheresis.
a significant increase in cell viability was noticed in the enriched-aCSF (
A similar trend of increased cell viability by enriched-aCSF treatment was noticed in SH-SY5Y cells exposed to H2O2, but without reaching a statistical significance
while cell viability was reduced under Aβ, a significant increase in cell viability was noted in the enriched-aCSF treated cells
significantly suppressed in spleen lymphocytes treated with the enriched-aCSF compared to lymphocytes treated with (unenriched-) aCSF
This limiting of the lymphocytes is most likely a good thing under the guise of this paper because the suppression of lymphocytes likely helps with certain autoimmune disorders.
These results show that the “in/out” enriched-aCSF therapy was the most effective one, affecting both time of onset (EAE-control mice develop the disease at day 10 while the treated mice at day 14 post induction) and disease progression
Prolonged amelioration of EAE clinical symptoms during prolonged CSF exchange therapy: (in/out) enriched-aCSF protocol was more effective than (in) enriched-aCSF and (in/out) aCSF.
A trend of less demyelination in the LFB staining in the (in/out) enriched-aCSF treated- mice relative to the EAE-control mic
Our results show that elimination of endogenous CSF, and its replacement with MSC secretions enriched-aCSF ((in/out)-enriched-aCSF), delayed EAE onset and reduced the clinical score with indications of reduced axonal damage and demyelination.
in vitro and in vivo, has shown that MSCs can promote survival and axonal myelination in sensory dorsal root ganglia neurons and may be effective in non-inflammatory models of demyelination [
MSCs transplantation alone has been applied and tested with strong indications of beneficial effects in animal models of MS [22,23,24,25], stroke [26,27], traumatic brain injury [28], PD [29], schizophrenia, and autism
showing that local (intraventricular) transplantation of MSCs is more effective than intravenous administration
The feasibility of CSF exchange therapy reported here in the EAE model might possibly be applied to other neurodegenerative diseases of the CNS.
our approach of CSF exchange therapy could be beneficial for fully developed neurological diseases through a repeated application of the proposed CSF exchange protocol